Buserelin in the treatment of prostatic cancerROILA, F.Biomedicine & pharmacotherapy. 1989, Vol 43, Num 4, pp 279-285, issn 0753-3322Article

Ondansetron clinical pharmacokineticsROILA, F; DEL FAVERO, A.Clinical pharmacokinetics. 1995, Vol 29, Num 2, pp 95-109, issn 0312-5963Article

Optimal selection of antiemetics in children receiving cancer chemotherapyROILA, F; AAPRO, M; STEWART, A et al.Supportive care in cancer. 1998, Vol 6, Num 3, pp 215-220, issn 0941-4355Conference Paper

Management of cancer pain : ESMO Clinical RecommendationsJOST, L; ROILA, F.Annals of oncology. 2008, Vol 19, issn 0923-7534, ii119-ii121, SUP2Article

Control of acute cisplatin-induced emesis over repeat courses of chemotherapyROILA, F.Oncology. 1996, Vol 53, pp 65-72, issn 0030-2414, SUP1Conference Paper

Issues in the measurement of nauseaDEL FAVERO, A; TONATO, M; ROILA, F et al.British journal of cancer. 1992, Vol 66, pp S69-S71, issn 0007-0920, SUP19Article

Management of cancer pain: ESMO Clinical Practice GuidelinesJOST, L; ROILA, F.Annals of oncology. 2010, Vol 21, issn 0923-7534, v257-v260, SUP5Article

Malignant glioma : ESMO Clinical Recommendations for diagnosis, treatment and follow-upSTUPP, R; ROILA, F.Annals of oncology. 2008, Vol 19, issn 0923-7534, ii83-ii85, SUP2Article

Chemotherapy-induced nausea and vomiting : ESMO Clinical Recommendations for prophylaxisHERRSTEDT, J; ROILA, F.Annals of oncology. 2008, Vol 19, issn 0923-7534, ii110-ii112, SUP2Article

Reducing chemotherapy-induced nausea and vomiting : current perspectives and future possibilitiesDEL FAVERO, A; ROILA, F; TONATO, M et al.Drug safety. 1993, Vol 9, Num 6, pp 410-428, issn 0114-5916Article

Ondansetron plus dexamethasone compared to the standard metoclopramide combinationROILA, F.Oncology. 1993, Vol 50, Num 3, pp 163-167, issn 0030-2414Conference Paper

Management of venous thromboembolism (VTE) in cancer patients: ESMO Clinical Practice GuidelinesMANDALA, M; FALANGA, A; ROILA, F et al.Annals of oncology. 2011, Vol 22, issn 0923-7534, vi85-vi92, SUP6Article

New anti-emetic treatmentsROILA, F; GARASSINO, M; FATIGONI, S et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix43-ix47, SUP9Conference Paper

Comparative studies of various antiemetic regimensROILA, F; TONATO, M; BALLATORI, E et al.Supportive care in cancer. 1996, Vol 4, Num 4, pp 270-280, issn 0941-4355Article

Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice GuidelinesBOVELLI, D; PLATANIOTIS, G; ROILA, F et al.Annals of oncology. 2010, Vol 21, issn 0923-7534, v277-v282, SUP5Article

Management of venous thromboembolism in cancer patients : ESMO Clinical RecommendationsMANDALH, M; FALANGA, A; ROILA, F et al.Annals of oncology. 2008, Vol 19, issn 0923-7534, ii126-ii127, SUP2Article

Erythropolesis-stimulating agents in the treatment of anaemia in cancer patients: ESMO Clinical Practice Guidelines for useSCHRIJVERS, D; DE SAMBLANX, H; ROILA, F et al.Annals of oncology. 2010, Vol 21, issn 0923-7534, v244-v247, SUP5Article

Clinical and methodological issues in antiemetic therapy : a worldwide survey of experts' opinionsBALLATORI, E; ROILA, F; HESKETH, P et al.Supportive care in cancer. 1997, Vol 5, Num 4, pp 269-273, issn 0941-4355Article

A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatinAGLIETTI, L; ROILA, F; TONATO, M et al.Cancer chemotherapy and pharmacology. 1990, Vol 26, Num 3, pp 239-240, issn 0344-5704, 2 p.Article

Erythropoietins in cancer patients : ESMO Recommendations for useGREIL, R; THÖDTMAN, R; ROILA, F et al.Annals of oncology. 2008, Vol 19, issn 0923-7534, ii113-ii115, SUP2Article

Hematopoietic growth factors : ESMO Recommendations for the applicationsGREIL, R; PSENAK, O; ROILA, F et al.Annals of oncology. 2008, Vol 19, issn 0923-7534, ii116-ii118, SUP2Article

Prevention of cisplatin-induced emesisROILA, F; TONATO, M; BALLATORI, E et al.Lancet (British edition). 1992, Vol 340, Num 8825, issn 0140-6736, p. 972Article

A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomitingROILA, F; BASURTO, C; MINOTTI, V et al.Cancer chemotherapy and pharmacology. 1986, Vol 18, Num 1, pp 88-89, issn 0344-5704Article

Hematopoietic growth factors: ESMO Clinical Practice Guidelines for the applicationsCRAWFORD, J; CASERTA, C; ROILA, F et al.Annals of oncology. 2010, Vol 21, issn 0923-7534, v248-v251, SUP5Article

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the managementMANDALA, M; FALANGA, A; ROILA, F et al.Annals of oncology. 2010, Vol 21, issn 0923-7534, v274-v276, SUP5Article